Skip to main content

Table 4 Characteristics associated with the utilization of Trastuzumab among HER2-positive patients

From: Navigating the implementation gap for Trastuzumab's journey from health insurance to patient access: a preliminary study in a hospital in China

 

Odds ratio (OR)

(95%CI)

P value

Age

  < 35

1.00

  

 35–44

0.62

(0.12, 3.07)

0.555

 45–54

0.59

(0.13, 2.61)

0.484

 55–64

0.33

(0.07, 1.56)

0.162

 ≥ 65

0.09

(0.01, 0.52)

0.008

TNM Stage

1.60

(1.10, 2.32)

0.015

Occupation

 Employed

1.00

  

 Freelancer or unemployed

0.54

(0.18, 1.64)

0.276

 Farmer

4.86

(0.55, 42.86)

0.155

 Retired

3.85

(1.53, 9.65)

0.004

 Other

1.50

(0.73, 3.08)

0.267

Education level

 Junior high school or below

1.00

  

 High school or technical school

0.45

(0.16, 1.30)

0.142

 Bachelor's degree or associate degree

0.51

(0.17, 1.56)

0.247

Insurance Type

 UEBMI

1.00

  

 URRBMI

0.57

(0.25, 1.30)

0.181

 Self-pay

1.08

(0.41, 2.86)

0.872

Number of childbirths

0.79

(0.49, 1.26)

0.318

Covered by basic medical insurance

8.65

(4.13, 18.12)

 < 0.001

  1. Bold indicates significant at alpha = 0.001 level